Hungary-Serbia IPA HUSRB/1203/214/025

of new psychoactive substances, drugs and related compounds analysed in the scope of the Novi Sad - Szeged cross-border project (NCTCNSHIFSSZ12) are relesead. The intructions for using the databases can be found on this link.

The Hungarian channel M1 presented report (partly in Serbian, partly with Serbian subtitles) about project's (HUSRB/1203) targets and prospective effects.

The report can be found here. Watch the '12. rész' (12th episode)!

In the frame of Hungary - Serbia IPA Cross-border Co-operation Programme (HUSRB/1203), three training courses and two project meetings were realized.

Trip summaries and pictures on the events can be found here: Monthly project meeting, 09/2013, Monthly project meeting, 10/2013, Advanced training on devices, Training on chemistry of designer drugs, Training on chemical analysis of designer drugs

(FT-IR, GC-MS, HPLC, rotary evaporation system) . After installation and testing of the instruments, trainings on theirs regular operations were also provided by factory trained service personnel. Experimental works with the procured analytical instruments started. The details of this period can be found here.

Opening Meeting of the project entitled "Novi Sad - Szeged cross-border cooperation in development of harmonized methods and production of common database for the analysis of designer drugs" was held in Novi Sad.

Trip summary and pictures on the event can be found here.

The project entitled started on 1st of March, 2013 by co-operation of Department of Organic Analytical Chemistry, Szeged Regional Laboratory with Republic of Serbia, Criminalistic Police Department, National Forensic Center, Regional Division in Novi Sad.

The main objective of this Project is to strengthen the capacity of the police forensic laboratory and criminalistic police officers for chemical analysis of drugs in the border areas of the two countries, in order to combat illicit drug trafficking and organized crime.

The details of the project can be found here.